Just published…With ~50% patients not requiring additional treatment for 9 mon…


Just published…With ~50% patients not requiring additional treatment for 9 months after the last CLS-TA treatment, demonstrates the potential for durability with the suprachoroidal platform & small molecule suspensions such as CLS-TA.
#retina #eyes
https://t.co/JRiSW8r5ht


Source by Thomas Ciulla, MD, MBA

Return to main website.